Planned consultation to address growing safety concerns of unapproved medicinal cannabis products in Australia

News Healthcare & Pharma Consultations

Date: 4th Aug, 2025 Source: Therapeutic Goods Administration (TGA) Country: Australia Original Source

Brief

"On August 4, 2025, the Therapeutic Goods Administration (TGA) issued an update regarding Planned consultation to address growing safety concerns of unapproved medicinal cannabis products in Australia. The TGA will conduct a public consultation to gather information on stakeholder knowledge and experiences with unapproved medicinal cannabis products, focusing on regulatory oversight and market controls for quality and safe use."

This content is restricted.

Highlights content goes here...

This content is restricted.

Therapeutic Goods Administration (TGA)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

Planned consultation to address growing safety concerns of unapproved medicinal cannabis products in Australia

Brief

Therapeutic Goods Administration (TGA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

Planned consultation to address growing safety concerns of unapproved medicinal cannabis products in Australia

Brief

Therapeutic Goods Administration (TGA)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.